Read + Share
Amedeo Smart
Independent Medical Education
Harrison SA, Rolph T, Knot M, Dubourg J, et al. FGF21 Agonists: An Emerging Therapeutic for Metabolic Dysfunction-Associated Steatohepatitis and Beyond. J Hepatol 2024 May 4:S0168-8278(24)00332-5. doi: 10.1016/j.jhep.2024.PMID: 38710230
Email
LinkedIn
Facebook
Twitter
Privacy Policy